India Markets: SAIL F&O Ban, IPO Frenzy, Corporate News

On August 24, 2026, Steel Authority of India (SAIL) shares faced a ban on fresh Futures and Options (F&O) positions, marking a notable market restriction. This development occurred amidst a flurry of corporate activities, including new IPO listings and significant company-specific updates.

IPO Activity and Subscription Rates

The Indian bourses are preparing for the listing of two new entities, Horizon Industrial Parks and Lalithaa Jewellery Mart.

• Horizon Industrial Parks’ IPO recorded a subscription of 1.52 times.
• Lalithaa Jewellery Mart’s IPO garnered substantial investor interest, subscribed 62.97 times.

Key Corporate Financials and Regulatory Updates

Caplin Point Laboratories underwent an unannounced inspection by the US Food and Drug Administration (USFDA) at its Caplin Steriles injectable and ophthalmic manufacturing facility located in Gummidipoondi, Tamil Nadu. Meanwhile, Federal Bank’s board approved a plan to secure up to $500 million through foreign currency-denominated bonds, facilitated by its IFSC Banking Unit (IBU) at GIFT City.

Manipal Health Enterprises reported mixed financial results for Q1 FY27.

• Consolidated net profit decreased by 7.48% to Rs 231.65 crore, down from Rs 250.37 crore in Q1 FY26.
• Revenue from operations saw a significant year-on-year increase of 38.12%, reaching Rs 3,090.63 crore.

B.R.Goyal Infrastructure secured a work order valued at Rs 151.06 crore from the National Highways Authority of India (NHAI) for a user fee agency at the Jajau Fee Plaza in Madhya Pradesh. NATCO Pharma received a Form 483 with four observations from the US FDA following an inspection of its Visakhapatnam manufacturing plant. Separately, Mamata Machinery was granted a patent in India for its Quadra 600 machine technology.

These varied corporate announcements underscore a dynamic period across India’s market, reflecting regulatory scrutiny, strategic financial maneuvers, and operational achievements among key players.